Mar 7, 2024 | Ad-hoc, Featured news, Finance, News, Press
Group sales rise to CHF 577.3 million (+8.6%) in 2023. EBITDA at CHF 166.7 million (+3.9%) with a margin of 28.9%. Strong Swiss franc: In local currencies sales growth is 12.8% and EBITDA-margin 30.5%. Total investments of CHF 269.0 million and net creation of 230 new...
Are you ready to dive into the fascinating universe of peptides and oligonucleotides?
Sign up for our newsletter and receive the latest updates directly in your inbox.
"*" indicates required fields